Neuropathology of PARK14 is identical to idiopathic Parkinson's disease

PLA2G6mutations and Parkinsonism: Long-term follow-up of clinical features and neuropathology

(2016) Christine Klein et al.   MOVEMENT DISORDERS

Impairment of PARK14-dependent Ca2+ signalling is a novel determinant of Parkinson’s disease

(2016) Qingde Zhou et al.   Nature Communications

Extensive aggregation of α-synuclein and tau in juvenile-onset neuroaxonal dystrophy: an autopsied individual with a novel mutation in the PLA2G6 gene-splicing site

(2013) Yuichi Riku et al.   Acta Neuropathologica Communications

Four novel rare mutations of PLA2G6 in Chinese population with Parkinson's disease

(2012) Ya-Xing Gui et al.   PARKINSONISM & RELATED DISORDERS

Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations

(2010) Coro Paisán-Ruiz et al.   NEUROBIOLOGY OF AGING

Characterization of PLA2G6 as a locus for dystonia-parkinsonism

(2008) Coro Paisan-Ruiz et al.   ANNALS OF NEUROLOGY

Neurodegeneration associated with genetic defects in phospholipase A2

(2008) A. Gregory et al.   NEUROLOGY